Antonio
Monge Vega
Investigador hasta 2013
Paul Sabatier University
Tolosa, FranciaPublicaciones en colaboración con investigadores/as de Paul Sabatier University (9)
2014
-
Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents
Molecules, Vol. 19, Núm. 2, pp. 2166-2180
2013
-
New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities
Molecules, Vol. 18, Núm. 4, pp. 4718-4727
2012
-
Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4- phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives
Molecules, Vol. 17, Núm. 8, pp. 9451-9461
2011
-
Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships
Experimental Parasitology, Vol. 128, Núm. 2, pp. 97-103
-
New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities
Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 15, pp. 4498-4502
-
Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives
Experimental Parasitology, Vol. 127, Núm. 4, pp. 745-751
2008
-
Antiplasmodial structure-activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide derivatives
Experimental Parasitology, Vol. 118, Núm. 1, pp. 25-31
2006
-
Antiplasmodial activity of 3-trifluoromethyl-2-carbonylquinoxaline di-N-oxide derivatives
Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences, Vol. 42, Núm. 3, pp. 357-361
2005
-
Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives
Arzneimittel-Forschung/Drug Research, Vol. 55, Núm. 12, pp. 754-761